insights_auto
Why is ORX up 5.76%?
Dive Deeperchevron_right
ORX:STO
Orexo AB
SEKÂ 0.90
arrow_upward
+5.76%(+0.049) 1D
Nov 17, 5:29:55 PM GMT+1 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ORX...
Open
SEKÂ 0.83
High
SEKÂ 0.98
Low
SEKÂ 0.83
Mkt. cap
315.79M
Avg. vol.
790.03K
Volume
719.07K
P/E ratio
0.07
52-wk high
SEKÂ 22.55
52-wk low
SEKÂ 0.80
EPS
SEKÂ 13.61
Shares outstanding
35.13M
No. of employees
55
Open
SEKÂ 0.83
High
SEKÂ 0.98
Low
SEKÂ 0.83
Mkt. cap
315.79M
Avg. vol.
790.03K
Volume
719.07K
P/E ratio
0.07
52-wk high
SEKÂ 22.55
52-wk low
SEKÂ 0.80
EPS
SEKÂ 13.61
Shares outstanding
35.13M
No. of employees
55
News stories
From web sources and news partners
BigGo Finance
·
1 hour ago
New York Stocks Slip a Day Before Nvidia Earnings; S&P 500, Nasdaq Fall for Fourth Straight Session
ChartMill
·
1 hour ago
S&P 500 After-Hours Gainers for Nov. 17, 2026
FXStreet
·
2 hours ago
Dow Jones Industrial Average slides on NSA outage, then Nvidia beats
Traders Union
·
2 hours ago
Ryan Detrick: Technology stocks outperformed S&P 500 while 75 stocks declined
Profile
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
About Orexo AB
CEONikolaj Sørensen
Employees55
Founded1995
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteorexo.com